Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 2.89 billion. The enterprise value is 2.64 billion.
Market Cap | 2.89B |
Enterprise Value | 2.64B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025.
Earnings Date | Aug 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 79.07 million shares outstanding.
Current Share Class | 44.07M |
Shares Outstanding | 79.07M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 51.82% |
Owned by Institutions (%) | 19.22% |
Float | 35.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 78.60 |
PS Ratio | 5.30 |
PB Ratio | 3.53 |
P/TBV Ratio | 14.14 |
P/FCF Ratio | n/a |
P/OCF Ratio | 65.12 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -28.94 |
EV / Sales | 4.84 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -210.95 |
Financial Position
The company has a current ratio of 2.37
Current Ratio | 2.37 |
Quick Ratio | 2.27 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -211.00 |
Financial Efficiency
Return on equity (ROE) is -10.64% and return on invested capital (ROIC) is -6.29%.
Return on Equity (ROE) | -10.64% |
Return on Assets (ROA) | -5.36% |
Return on Invested Capital (ROIC) | -6.29% |
Return on Capital Employed (ROCE) | -10.51% |
Revenue Per Employee | 1.29M |
Profits Per Employee | -215,741 |
Employee Count | 411 |
Asset Turnover | 0.54 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Nordhealth AS has paid 12.06 million in taxes.
Income Tax | 12.06M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.00% in the last 52 weeks. The beta is 0.44, so Nordhealth AS's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | +26.00% |
50-Day Moving Average | 37.14 |
200-Day Moving Average | 37.91 |
Relative Strength Index (RSI) | 50.94 |
Average Volume (20 Days) | 2,943 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 545.88 million and -91.26 million in losses. Loss per share was -1.15.
Revenue | 545.88M |
Gross Profit | 188.53M |
Operating Income | -86.37M |
Pretax Income | -79.19M |
Net Income | -91.26M |
EBITDA | -7.83M |
EBIT | -86.37M |
Loss Per Share | -1.15 |
Balance Sheet
The company has 252.99 million in cash and n/a in debt, giving a net cash position of 252.99 million or 3.20 per share.
Cash & Cash Equivalents | 252.99M |
Total Debt | n/a |
Net Cash | 252.99M |
Net Cash Per Share | 3.20 |
Equity (Book Value) | 818.96M |
Book Value Per Share | 10.36 |
Working Capital | 194.66M |
Cash Flow
In the last 12 months, operating cash flow was 44.44 million and capital expenditures -56.95 million, giving a free cash flow of -12.52 million.
Operating Cash Flow | 44.44M |
Capital Expenditures | -56.95M |
Free Cash Flow | -12.52M |
FCF Per Share | -0.16 |
Margins
Gross margin is 34.54%, with operating and profit margins of -15.82% and -16.72%.
Gross Margin | 34.54% |
Operating Margin | -15.82% |
Pretax Margin | -14.51% |
Profit Margin | -16.72% |
EBITDA Margin | -1.44% |
EBIT Margin | -15.82% |
FCF Margin | n/a |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -3.15% |
FCF Yield | -0.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |